Laobaixing Pharmacy (603883) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.075x

Based on the latest financial reports, Laobaixing Pharmacy (603883) has a cash flow conversion efficiency ratio of 0.075x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥538.25 Million ≈ $78.76 Million USD) by net assets (CN¥7.20 Billion ≈ $1.05 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Laobaixing Pharmacy defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Laobaixing Pharmacy - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Laobaixing Pharmacy's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Laobaixing Pharmacy Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Laobaixing Pharmacy ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sk Gas KO:018670	0.070x
Labrador Iron Ore Royalty Corp TO:LIF	0.051x
Centuria Capital Group AU:CNI	0.019x
Regis Healthcare Ltd AU:REG	-5.831x
Anhui Estone Materials Technology Co Ltd SHG:688733	-0.014x
OC OERL.CORP ADR 2 SF 1 F:OBH0	N/A
Shanghai SMI Holding Co Ltd SHG:600649	0.039x
Dampskibsselskabet Norden AS CO:DNORD	0.124x

Annual Cash Flow Conversion Efficiency for Laobaixing Pharmacy (2011–2025)

The table below shows the annual cash flow conversion efficiency of Laobaixing Pharmacy from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Laobaixing Pharmacy worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥7.00 Billion ≈ $1.02 Billion	CN¥3.14 Billion ≈ $459.87 Million	0.449x	+58.91%
2024-12-31	CN¥7.17 Billion ≈ $1.05 Billion	CN¥2.03 Billion ≈ $296.53 Million	0.283x	-24.52%
2023-12-31	CN¥7.29 Billion ≈ $1.07 Billion	CN¥2.73 Billion ≈ $399.46 Million	0.375x	+14.86%
2022-12-31	CN¥7.10 Billion ≈ $1.04 Billion	CN¥2.31 Billion ≈ $338.66 Million	0.326x	-32.20%
2021-12-31	CN¥4.78 Billion ≈ $699.30 Million	CN¥2.30 Billion ≈ $336.31 Million	0.481x	+59.66%
2020-12-31	CN¥4.81 Billion ≈ $703.18 Million	CN¥1.45 Billion ≈ $211.81 Million	0.301x	+13.04%
2019-12-31	CN¥3.87 Billion ≈ $567.00 Million	CN¥1.03 Billion ≈ $151.09 Million	0.266x	-1.66%
2018-12-31	CN¥3.37 Billion ≈ $493.04 Million	CN¥913.03 Million ≈ $133.60 Million	0.271x	+70.76%
2017-12-31	CN¥3.10 Billion ≈ $453.79 Million	CN¥492.13 Million ≈ $72.01 Million	0.159x	-1.45%
2016-12-31	CN¥1.95 Billion ≈ $284.66 Million	CN¥313.26 Million ≈ $45.84 Million	0.161x	+43.53%
2015-12-31	CN¥2.29 Billion ≈ $335.39 Million	CN¥257.15 Million ≈ $37.63 Million	0.112x	-50.72%
2014-12-31	CN¥1.09 Billion ≈ $158.86 Million	CN¥247.14 Million ≈ $36.17 Million	0.228x	+52.82%
2013-12-31	CN¥916.46 Million ≈ $134.11 Million	CN¥136.52 Million ≈ $19.98 Million	0.149x	-26.69%
2012-12-31	CN¥732.59 Million ≈ $107.20 Million	CN¥148.85 Million ≈ $21.78 Million	0.203x	-6.94%
2011-12-31	CN¥607.41 Million ≈ $88.88 Million	CN¥132.62 Million ≈ $19.41 Million	0.218x	--

About Laobaixing Pharmacy

SHG:603883 China Pharmaceutical Retailers

Market Cap

$1.31 Billion

CN¥8.97 Billion CNY

Market Cap Rank

#7904 Global

#1887 in China

Share Price

CN¥11.82

Change (1 day)

-0.17%

52-Week Range

CN¥11.62 - CN¥21.50

All Time High

CN¥331.82